EUVIMEDEUVIMED entdecken
Crossref

Anti-Müllerian hormone as a supplementary test in women not meeting ultrasonographic polycystic ovary morphology criteria

Dayong Lee, Kyu R Hwang, Sunmie Kim, Young M Choi, Jin J Kim

Reproductive BioMedicine Online · 2026

DOI: 10.1016/j.rbmo.2026.105863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2026. Verfasst von Dayong Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul, Korea; Department of Obstetrics and Gynecology, Seoul National Univer…. Hauptthemen laut MEDLINE: Anti-Mullerian Hormone, Polycystic Ovary Syndrome. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Is supplementary anti-Müllerian hormone (AMH) testing of diagnostic value in symptomatic women who fail to meet the updated ultrasonographic (USG) polycystic ovary morphology (PCOM) criteria? DESIGN: Cross-sectional study analysing 213 women with irregular menstruation or hyperandrogenism who met the original Rotterdam PCOM criteria. Although 95 met the updated USG-PCOM criteria and were diagnosed with polycystic ovary syndrome (PCOS), the remaining 118 failed to meet the updated USG criteria and served as the main analysis group. RESULTS: Among the 118 women, 75.4% (n = 89) met the optimal age-group-specific and AMH cut-off for Korean women, and their geometric mean AMH concentration was 9.8 ng/ml. These 89 individuals demonstrated significantly higher waist circumference, blood pressure, haemoglobin A1c concentrations and worse lipid profiles than 267 matched controls. Their metabolic and androgenic patterns were comparable to the 95 women diagnosed with PCOS via USG-PCOM, of whom 93.7% (n = 89) also fulfilled the AMH-based PCOM criteria. CONCLUSIONS: Although concurrent use of AMH and USG is discouraged to prevent overdiagnosis, supplementary AMH testing is valuable for symptomatic women who fail to meet the updated USG-PCOM criteria. When AMH defines PCOM, these women can be diagnosed with PCOS, exhibiting clinical and metabolic features similar to USG-confirmed PCOS and distinct from controls. Additional AMH testing is unnecessary when USG-PCOM is already evident, as AMH elevation is predominantly present; however, it should be considered in USG-negative symptomatic women. Identifying these patients enables earlier metabolic intervention, potentially outweighing overdiagnosis risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Mullerian HormonePolycystic Ovary SyndromeHumansFemaleCross-Sectional StudiesUltrasonographyAdultHyperandrogenismYoung AdultOvary

Stichwörter der Autor:innen

anti-Müllerian hormonehyperandrogenismirregular menstruationpolycystic ovary morphologypolycystic ovary syndromepolyendocrine metabolic ovarian syndrome

Substanzen

Anti-Mullerian Hormone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul, Korea; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea; Department of Obstetrics and Gynecology, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul,…
  • Department of Obstetrics and Gynecology, Grace Hospital, Goyang, Korea.

Zitieren

APA

Lee, D., Hwang, K. R., Kim, S., Choi, Y. M., & Kim, J. J. (2026). Anti-Müllerian hormone as a supplementary test in women not meeting ultrasonographic polycystic ovary morphology criteria. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2026.105863

Vancouver

Lee D, Hwang KR, Kim S, Choi YM, Kim JJ. Anti-Müllerian hormone as a supplementary test in women not meeting ultrasonographic polycystic ovary morphology criteria. Reproductive BioMedicine Online. 2026. doi:10.1016/j.rbmo.2026.105863

BibTeX
@article{Lee2026,
  author = {Lee, Dayong and Hwang, Kyu R and Kim, Sunmie and Choi, Young M and Kim, Jin J},
  title = {Anti-Müllerian hormone as a supplementary test in women not meeting ultrasonographic polycystic ovary morphology criteria},
  journal = {Reproductive BioMedicine Online},
  year = {2026},
  doi = {10.1016/j.rbmo.2026.105863}
}
Kostenlos starten →